Global Demand for Nuclear Medicine Market

Nuclear medicine is redefining the paradigms of medical imaging by providing detailed and accurate results as well as early detection of potentially fatal conditions. This has brought more consumers in the folds of the global nuclear medicine market, leading to the market growing at a steady rate in the coming years, says a study by Transparency Market Research. According to the report, titled ‘Nuclear Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023.’

Nuclear medicine entails the use of small amounts of radioactive isotopes. Diagnoses are conducted using different kinds of radiological scanning techniques such as computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), and magnetic resonance imaging (MRI).

The use of nuclear medicine is increasingly seen in the diagnosis and treatment of neurological disorders, cardiovascular disease, cancers, and other disorders and abnormalities within the body. With a growing demand for accurate diagnosis and treatment, technologically sophisticated healthcare solutions are much in demand. This augurs well for the growth of the global nuclear medicine market. The TMR report also states that new advancements in neurological applications will aid the growth of the global nuclear medicine market.

According to the report, strict regulatory guidelines governing the use of nuclear medicine will create obstacles in the path of the market’s growth. At the same time, the use of traditional diagnostic procedures still continues to give competition to nuclear medicine, which could restrain the market, too. The world over, there is still a dearth of highly trained and experienced professionals in the field of nuclear medicine. A shortage of radioactive isotopes could also potentially impede the growth of the nuclear medicine market.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4672

The report segments the global nuclear medicine market on the basis of application and geography. Nuclear medicine is primarily used in diagnostic and therapeutic applications, which form the two application segments of the nuclear medicine market.

The diagnostic applications segment is further divided into: neurology, nephrology, cardiovascular, pulmonology, oncology, and hepatology. The use of nuclear medicines is seen most widely in cancer treatment and scar tissue removal.

From the geographical standpoint, the global market for nuclear medicine is segmented into the following markets: Asia Pacific, North America, Europe, the Middle East and Africa, and Rest of the World. Although North America was the most dominant market for nuclear medicine in the world in 2015, the fastest growth rate can be expected from Asia Pacific. Countries in the region are beginning to see an upswing in the incidence of cancer and cardiovascular diseases.

The report includes a thorough evaluation of the performance and standing of leading companies in the nuclear medicine market. These include: G.E Healthcare, Ashby Gorman Baker Ltd., Pinestar Technology, Inc., and Mediso Ltd.

Emerging Opportunities in Knee Implants Market

Knee implant procedures are done when a patient has knee pain, a traumatic injury or a disability from rheumatoid arthritis, or osteoarthritis. In the surgical process, a surgeon implants the device (artificial device) and replaces the damaged knee with it. There are many different types of implants - which are made of metal alloys, strong plastic parts or ceramic material.

The knee implants market will grow due to factors such as increase in the rate of age related diseases like osteoporosis and arthritis, diabetes, obesity, ageing population and injuries related to sports. However due to technological advances such as minimal invasive surgery, better implant materials and better success rates, even the younger population are able to undergo knee replacement surgery.

Technological advancements in knee implants such as minimally invasive surgery have made it possible to have procedures with small incisions, lower blood loss, lesser tissue injuries and faster recovery time. Growing awareness among patients regarding their health will also help to drive the market.

The knee implants market has had to face some challenges due to the economic slowdown. This has resulted in many hospitals cutting down their costs to increase their market share. Many patients are reluctant to go in for knee implantation procedures due to the high cost involved. Further, the knee implant market is also showing pressure due to the intense competition among manufacturers on the prices.

Presently, in this emerging market, both patients and surgeons have more options for implant due to the newer available techniques which are giving better outcomes for patients. This has given options for implant manufacturers companies to provide new product solutions.

The global knee implants market was USD 8.4 billion in 2011 and it is forecasted that this market will reach USD 15 billion in 2018 with compound annual growth rate of 8.64% during 2011 to 2018. The U.S. and Europe are the two big markets for knee implants and both the countries enjoy more than 70% market share of global knee implants.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=513

The leading players in the knee implants market are B.Braun, Smith and Nephew, Stryker, Zimmer, and Depuy. They accounted for almost 80% of the total market. Zimmer is the market leader among them with 30% market share. The medical device manufacturing companies are increasing their market share with marketing campaigns and awareness.

This market research report analyzes important market segments, and major geographies. This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

mHealth Monitoring And Diagnostic Medical Devices Market witnesses a year of significant changes

Transparency Market Research recently announced the publication of a new market research report, titled “mHealth Monitoring And Diagnostic Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019,” which provides a comprehensive market overview, including the market drivers and barriers, product segmentation, current market trends, geographical segmentation, and competitive landscape of the market.According to the research study, in 2012, the global mHealth monitoring and diagnostic medical devices market for was valued at US$0.6 bn and is estimated to reach a value of US$8 bn by the end of 2019, exhibiting an enormous 43.30% CAGR between 2013 and 2019.

mHealth monitoring and diagnostic medical devices are used to deliver healthcare facilities with the help of communication devices, including tablet computers, mobile phones, and PDAs. The global market for mHealth monitoring and diagnostic medical devices is an emerging market and the demand has been growing at a fast pace due to the rising prevalence of chronic diseases.

The global market for mHealth monitoring and diagnostic medical devices has been segmented on the basis of product type into sleep apnea monitors, blood pressure monitors, multi-parameter monitors, pulse oximeters, cardiac monitors, glucose monitors, and others. Among these, the glucose monitors segment is projected to exhibit an explosive 49.40% CAGR between 2013 and 2019. The increasing incidence of diabetes across the globe, along with the increasing demand for minimally invasive glucose monitoring devices, is estimated to fuel the growth of the glucose monitors segment in the next few years.

Moreover, the tremendous rise in the number of smartphones and innovations in mHealth devices due to technological advancements are other factors that are driving the overall market. Furthermore, the multi-parameter monitors segment is anticipated to witness rapid growth owing to rising awareness regarding healthy lifestyles and fitness in several developed economies.

The global market for mHealth monitoring and diagnostic medical devices has been divided on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World. Currently, the North America market accounts for the largest share in the overall market, thanks to the presence of several manufacturers in the region, the growing population owning a smart consumer electronic device such as tablets or smartphones, technological developments, and rising awareness regarding new technology and devices.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2018

On the other hand, the Asia Pacific market for mHealth monitoring and diagnostic medical devices is considered as one of the most favorable markets throughout the forecast period. This region is estimated to register a high growth rate, owing to the increasing geriatric population, growing prevalence of chronic diseases, rising awareness regarding the benefits of diagnostic devices, and increasing demand for home care monitoring devices. In addition, the growing use of smartphones in several countries such as Singapore, India, China, Australia, New Zealand, and Japan is further driving the global market for mHealth monitoring and diagnostic medical devices.

Furthermore, the study talks about the competitive landscape of the market, including detailed profiles of the major players. Some of the prominent players operating in the global market for mHealth monitoring and diagnostic medical devices are BioTelemetry Inc., F. Hoffmann La-Roche Ltd., AT&T, Inc., Johnson & Johnson, DexCom, Inc., Bayer HealthCare AG, Medtronic Inc., Boston Scientific Corporation, Masimo Corporation, Omron Healthcare, LifeWatch AG, and Dräger AG.

Hospital Acquired Disease Testing Market Dynamics and Opportunities Report by Transparency Market Research

Transparency Market Research has published a research report that discusses the trends and dynamics in the global hospital acquired disease testing market. The research report, titled “Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023,” includes thorough research on the market collated by industry experts.

The research report includes an evaluation of the diagnostic tests performed to diagnose hospital-related infections. Also known as nosocomial infections, hospital acquired diseases have become a growing cause of morbidity across the world. The research report has used SWOT analysis to identify the strengths, weaknesses, opportunities, and threats of the market. Furthermore, it also includes Porter’s five forces analysis that highlights the threat of new entrants, the threat of substitute products or services, the bargaining power of customers (buyers), the bargaining power of suppliers, and the intensity of competitive rivalry.

According to the research report, the global hospital acquired disease testing market was valued at US$0.4 bn in 2014 and is likely to reach US$2.0 bn by 2023, rising at a CAGR of 19.9% from 2015 to 2023. This growth will be attributable to the growing number of cases of nosocomial infections.

In the past few years, the high incidence of nosocomial infections has led to a high rate of morbidity. This is especially seen amongst patients who have a weaker immune system and fall prey to poor hygiene conditions in the hospitals. The growing pool of geriatrics is the primary reasons for the growth in the prevalence of hospital acquired diseases across the globe.

The global hospital acquired disease testing market has been segmented on the basis of test and geography. On the basis of test, this market is segmented into urinary tract infections, pneumonia infections, bloodstream-associated infections, MRSA infections, surgical site infections, and others. Geographically, this market is segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa.

Of all the segments based on test type, the hospital acquired urinary tract infection diagnostics segment holds a dominating share in the overall market due to the high prevalence of urinary infections and its impact on morbidity. Analysts predict that this segment will continue to show its dominance in the market through 2023. Additionally, the market for testing solutions such as surgical site infections and pneumonia (ventilator associated and hospital associated infections) will also expand due to the high prevalence of these conditions in emerging economies in Latin America, Asia Pacific, and other developing regions.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1759

Some of the top players mentioned in the research report about the global hospital acquired disease testing market are Diatherix Laboratories Inc., Qiagen GmbH, Gen-Probe Inc., L Hoffman La Roche, Cepheid, Inc., Meridian Biosciences, Life Technologies Corporation, Nordion, Inc., and Cantel Medical Corporation. The research report also offers a detailed explanation of the competitive landscape of the global hospital acquired disease testing market. Furthermore, it also assesses the financial overview, research and development activities, business and marketing strategies, product portfolio, and strategic mergers and acquisitions of these top players in the overall market.

A brief review of Anti-Adhesion Products Market

Adhesion is one of the common problems affecting almost 55% to 90% patients followed by surgery. Adhesion is a band of scar tissue formed between organs and tissue after a surgery as a part of a normal healing process. However, when it connects wrong tissues into each other, adhesions may lead to severe clinical symptoms such as pelvic pain, intestinal blockage, infertility and loss of sensation depending on the location and size of the adhesions. Adhesions are most common after surgeries such as abdominal surgery, thoracic surgery, gynaecological surgery and plastic surgery. After abdominal surgery, bowels and pelvic organs may adhere with each other as a result of adhesion causing risks for small bowel obstruction and severe pain. The various types of adhesions based on their locations are abdominal adhesions, intestinal adhesions, intraperitoneal adhesions and pelvic adhesions.

Some of the anti-adhesion products available in the market are Adept (Baxter), Seprafilm (Genzyme), INTERSEED (Johnson & Johnson) and Surgiwrap (MAST Biosurgery). The market for anti-adhesion products can be segmented on the basis of types of surgery such as abdominal surgery, gynecological surgery and other surgical procedures. The market for anti-adhesion products is growing due to large number incidences of adhesion associated with various surgeries. Usually 55% to 90% patients undergoing abdominal and gynecological surgeries face adhesion problems. Presently, North America represents the largest market as a number of products have been approved by FDA. Asia-Pacific is experiencing growth as large number of patients are undergoing abdominal and gynecological surgeries. In the coming future the market will witness growth with the introduction of new products with more efficacy.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1506

Some of the major vendors operating in this market are Johnson & Johnson, Baxter International, WL Gore, Anika Therapeutics, Inc., Angiotech Pharmaceuticals, Inc., Genzyme Corporation, LifeCell Corporation and MAST Biosurgery AG.

Blood Pressure Monitoring Testing Market Witnesses Rising Demand and Investment from R&D Activities

The global blood pressure monitoring testing market was recorded at US$1.7 bn in 2012. It is exhibiting a CAGR of 11.50% within a forecast period of 2013 and 2019, by the end of which this market will reach US$3.6 bn. This data is provided through a research report by Transparency Market Research, titled “Blood Pressure Monitoring Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.” The report incorporates all values essential in gauging the driving and restraining factors concerned with this market and provides a logical forecast for the same.

According to the report, the global blood pressure monitoring testing market is being driven by the increasing number of patients being diagnosed with high blood pressure. The reasons for high blood pressure include the increasing levels of stress faced on a daily basis, the reducing amount of physical activity performed by individuals, and the rising percentage of the geriatric demographic.

Nearly 7 mn people in the U.S. die from hypertension-related diseases each year. In 2012, about 76 mn U.S. citizens were suffering from high blood pressure. This illustrates the importance of hypertension in terms of being a global health threat.

Medical research and diagnostic numbers have shown that people above the age of 50 have a 90% chance of developing hypertension. Some of the most common causes of high blood pressure are social, metabolic, and behavioral. Other causes include consumption of toxins including alcohol and tobacco. All these reasons are contributing to a large number of people suffering from blood pressure issues, creating a high demand from the global blood pressure monitoring testing market.

The report provides a segmented analysis of the global blood pressure monitoring testing market in terms of types and geography.

According to type, the segments of the global blood pressure monitoring testing market are blood pressure instrument accessories, blood pressure transducers, ambulatory blood pressure monitors, automated blood pressure monitors, and sphygmomanometers. The market is expected to be shaped by the growing adoption of digital sphygmomanometers, which is currently higher than the demand for mercury-based and aneroid variants. The digital ones are a lot simpler to use and can give a more accurate reading than conventional sphygmomanometers.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1630

An increasing number of people continue to suffer from blood pressure issues, owing to factors such as chronic disorders, diabetes, obesity, and congenital heart diseases. Regardless of the manner of incurring hypertension, the global blood pressure monitoring testing market and its segment of sphygmomanometers will continue to grow in value.

The report’s analysis of the global blood pressure monitoring testing market on the basis of geography involves the segmentation of the market into the four major regions of North America, Europe, Asia Pacific, and the Rest of the World. As per the report, North America dominated the global blood pressure monitoring testing market in 2012. Hypertension was one of the most common reasons for cardiovascular diseases in North America, creating high demand from this market.

Key players in the global blood pressure monitoring testing market are Welch Allyn, Spacelabs Healthcare, Philips Healthcare, Omron Healthcare, Inc., Nihon Kohden Corporation, Suntech Medical, Inc., Masimo Corporation, GE Healthcare, Covidien PLC, and A&D Medical, Inc.

Advanced Remote Patient Monitoring Systems Market Segment Forecast up to 2020

Remote patient monitoring systems refer to a technology that enable monitoring of patients outside the conventional clinic or hospital premises. The main concept behind remote patient monitoring is to avoid the inconvenience caused to critical patients. Advanced remote patient monitoring systems include sophisticated peripherals that facilitate real time audio and video service. This enables face to face interaction between the patients and medicine professionals. These systems are highly useful as it reduces the travel time of patients to clinics and improves the medical consultation. This can reduce mortality rates and enable efficient use of medical resources. The connectivity between the patients and medical professionals is attained using wireless technologies such as wireless local area networks (WLAN) and cellular networks. Advanced remote patient monitoring systems helps in avoiding emergency overcrowding, manage large number of patients and improved maintenance of electronic health records (EHR).

One of the major factors driving the advanced remote patient monitoring systems market is low treatment costs. Advanced remote patient monitoring systems reduce the expenses such as hospital admissions, travelling costs and others. Increasing number of patients with diseases such as diabetes, congestive heart diseases and others is major factor driving the demand for advanced and cost effective healthcare solutions. Monitoring systems deliver low cost, fast and reliable consulting of these diseases as compared to conventional consulting. Furthermore, advanced remote patient monitoring systems help the medical professional to monitor number of patients simultaneously from one place. This enables increased coverage of patient monitoring with less number of medical personnel.

With continuous monitoring of patients, the medical professionals can diagnose serious disorders in an early stage. This leads to improved patient care and reduced mortality rate. Furthermore, increasing adoption of mobile devices such as smartphones, tablet personal computers (PCs) and others is another factor boosting the advanced remote patient monitoring systems market.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3444

The advanced remote patient monitoring systems market is segmented based on the type of monitoring, end-user and geographic regions. The different types of monitoring include vital signs monitoring, diagnostic monitoring and specialized monitoring. Vital sign monitoring comprises blood pressure, pulse oximeters and other physical parameters. Diagnostic monitoring includes electrocardiogram (ECG) and others. Specialized monitoring includes disease specific monitoring such as anesthesia, diabetes - glucose, cardiac rhythm, respiratory and other disorder monitoring. The advanced remote patient monitoring systems market is segmented based on end-users as hospital based patients and telemedicine patients. Geographically, the advanced remote patient monitoring systems market is segmented into four major regions as North America, Europe, Asia Pacific and Rest of the World (RoW). At present, North America accounts for the largest share in terms of revenue in advanced remote patient monitoring systems market. This is mainly due to rising lifestyle diseases such as atherosclerosis, asthma, osteoporosis and other heart diseases. Additionally, availability of sophisticated monitoring devices is another factor responsible for this growth. North America is expected to remain the dominant market for the next few years owing to high investment in healthcare sector.

Some of the leading players in advanced remote patient monitoring systems market include Abbott Laboratories, Drager Medical GmbH, Covidien Ltd., GE Healthcare, Masimo Corporation, Johnson and Johnson Inc., Mindray Medical International Ltd., Natus Medical Inc., Mortara Instrument Inc., Nihon Kohden Corporation, Omron Healthcare Co. Ltd., Nonin Medical Inc., Koninklijke Philips N.V., Roche Diagnostics Ltd. and others.